These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1003 related items for PubMed ID: 10553155
1. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G. Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155 [Abstract] [Full Text] [Related]
2. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells. Guo W, Wang H, Zhao W, Zhu J, Ju B, Wang X. Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431 [Abstract] [Full Text] [Related]
3. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3). Zhang T, Westervelt P, Hess JL. Mod Pathol; 2000 Sep; 13(9):954-61. PubMed ID: 11007035 [Abstract] [Full Text] [Related]
4. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ. Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433 [Abstract] [Full Text] [Related]
5. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients. Lou Y, Ma Y, Sun J, Ye X, Pan H, Wang Y, Qian W, Meng H, Mai W, He J, Tong H, Jin J. Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332 [Abstract] [Full Text] [Related]
10. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution. Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z. Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151 [Abstract] [Full Text] [Related]
11. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report. Bergstrom SK, Gillan E, Quinn JJ, Altman AJ. J Pediatr Hematol Oncol; 1998 Dec; 20(6):545-7. PubMed ID: 9856675 [Abstract] [Full Text] [Related]
12. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene. Sato A, Imaizumi M, Hoshi Y, Rikiishi T, Fujii K, Kizaki M, Kagechika H, Kakizuka A, Hayashi Y, Iinuma K. Leuk Res; 2004 Sep; 28(9):959-67. PubMed ID: 15234573 [Abstract] [Full Text] [Related]
13. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement. Gau JP, Young JH, Lin TH, Yang YS. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412 [Abstract] [Full Text] [Related]